Endoscope Reprocessing Market - Global Outlook & Forecast 2022-2027

298 pages

100 tables

144 charts

5 region

19 countries

35 company

8 segments

Purchase Options

$3500.00
$3995.00
$4995.00
$1500.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE WAS VALUED AT USD 2.02 BILLION IN 2021 AND IS EXPECTED TO REACH USD 3.3 BILLION BY 2027, GROWING AT A CAGR OF 8.37%.

The Global Endoscope Reprocessing Market Research Report Includes Size in Terms of 

  • Product: Reprocessing Equipment, Disinfectants, Detergents, Drying, Storage & Transport Systems, Others.
  • End-User: Hospitals, Specialty Clinics & Medical Office Suites, Standalone Reprocessing Service Facilities, Others.
  • Geography: North America, APAC, Europe, Latin America, and MEA

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

GLOBAL ENDOSCOPE REPROCESSING MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2027)USD 3.3 Billion
Market Size (2021)USD 2.02 Billion
CAGR (2022-2027)8.37%
Base Year2021
Forecast Year2022-2027
Market SegmentsProduct (Reprocessing Equipment, Disinfectants, Detergents, Drying, Storage & Transport Systems, Others), End User (Hospitals, Specialty Clinics & Medical Office Suites, Standalone Reprocessing Service Facilities, Others)
Geographic AnalysisNorth America, APAC, Europe, Latin America, and MEA
Key VendorsSteris, Ecolab, Getinge AB, Olympus, Fortive
Interested in this Report?

Download a Sample!

MARKET INSIGHTS

The global endoscope reprocessing market was valued at USD 2.02 billion in 2021 and is expected to reach USD 3.3 billion by 2027, growing at a CAGR of 8.37% from 2022 to 2027. The global endoscope reprocessing market will likely witness incremental growth of over USD 1.2 billion and absolute growth of 62% during the forecast period. APAC is likely to be the fastest-growing region, with the highest CAGR of 9.60% during the forecast period. The region's main reason for fast growth is the growing availability of endoscope reprocessing systems, the presence of cheap labor, the low cost of manufacturing, and major technological advances in the healthcare sector.

Endoscope reprocessing is a multi-step process that involves effective cleaning, disinfection, and sterilization of endoscopy devices and their accessories. The high risk of infections associated with improper sterilization of endoscopes is majorly driving the demand for reprocessing equipment. The endoscope reprocessing market will flourish due to a focus on high cleaning standards and mounting pressures for sterilized and disinfected medical devices in hospitals and clinics.

The high usage of endoscopic devices mainly drives the global endoscope reprocessing market for diagnosis and treatment. This is due to the growing burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments leads to an increased risk of infections; hence, these are being disinfected and cleaned using reprocessing systems. The demand for these systems is likely to grow in healthcare centers. Still, the high cost of endoscopy, improper or under-reprocessing leading to infections, and the growing prominence of single-use bio processors can hinder the market's growth.

Gastrointestinal (GI) endoscopy is essential for identifying and treating gastrointestinal tract disorders. Gastrointestinal endoscopes can become highly contaminated with their frequent use in patients, as millions of endoscopy procedures are being performed in the US alone. Cleaning, disinfection, and sterilization process are vital for the prevention of infections caused due to the contamination of these endoscopes. Hence the demand for reprocessing endoscopes has become highly important.

MARKET TRENDS & DRIVERS

  • The rise in Target Population Requiring Endoscopic Interventions
  • Growing Risk of Developing Endoscope-Related Infections
  • Regulatory Guidelines Promoting Usage of Endoscope Reprocessing
  • Increasing Hospital Investments in Endoscopes & Reprocessing Systems

RISK OF GROWING TARGET POPULATION AND DEVELOPMENT OF ENDOSCOPIC INFECTIONS

The number of patients suffering from gastrointestinal diseases is rising across the world. These diseases are among the most costly and debilitating health conditions, accounting for about 3 million hospital admissions in the United States alone. The prevalence of these diseases is increasing the need for performing endoscopic procedures in various healthcare centers. An estimated 17 million lower GI endoscopies and about the same number of upper endoscopies are performed annually in the US. This initiates the risk of infections associated with the formation of biofilms due to their frequent usage. The infection rate approaches 1 in 10 million procedures. With the growing risk of these infections, the demand for endoscope reprocessing systems is growing.

THE GROWING TREND OF INCORPORATING TRACKING SOLUTIONS

Proper endoscope reprocessing is vital for patient safety. Ensuring that every step in the process is completed needs complex tracking and documentation. Eliminating manual documentation logs and ensuring the endoscope is disinfected and cleaned before using it in the procedure. Significant benefits of these tracking solutions include improved handling of endoscope complexity, integration with multiple systems, quality assurance of workflow, and optimization of return on investment.

TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH

Several manufacturers are emphasizing the automation of disinfection workflows to a large extent. This has also defined their production advancements and innovation strategies in recent years. For instance, in 2018, around $0.4 billion was invested in Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. Cleaning has always been challenging owing to the inability to inspect the cleanliness inside the lumens of an endoscope until now. The latest technological advancements have allowed the development of flexible inspection camera systems that can check an instrument's internal channels for debris and damage, which could help reduce infection rates.

HIGH COST OF ENDOSCOPY PROCEDURES AND REPROCESSING EQUIPMENT

The high cost associated with endoscopy lowers the number of endoscopic procedures performed on patients. Medical procedures such as endoscopies can be costly without insurance. The cost of a colonoscopy typically ranges between $1,250 to over $4,800 in the US, with an endoscopy's national average price of $2,750. Also, the equipment costs range from $114.07 to $280.71. The average reported repair cost—whether attributed to a leak test failure, damage during a visual inspection, or a failed cleaning verification test was estimated to be $5,833. Such high prices can limit the adoption of re-processing equipment.

IMPACT OF COVID-19 ON THE GLOBAL ENDOSCOPE REPROCESSING MARKET

Gastrointestinal complaints were frequent among COVID-19 patients, with possible occurrences of diarrhea, nausea, and vomiting. A March 2020 multicenter survey revealed near-universal exposure to COVID-19-positive patients in endoscopy units: 97.6% experienced a reduction in endoscopic activities, and 50% performed endoscopic procedures on COVID-19-positive patients. Hence, there was a moderate need for performing endoscopy procedures during COVID-19. Due to this, the demand for endoscope re-processing systems was high as there was a high risk of disease transmission among patients and healthcare providers.

MARKET SEGMENTATION

PRODUCT

In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market. The demand for disinfectants is high as there is a growing need for disinfecting endoscopes. By equipment, the market is segmented as automated endoscope reprocessors and disinfection & sterilization equipment. Automated reprocessors accounted for the highest share in the market compared to disinfection & sterilization systems as the demand for automatic reprocessing systems is proliferating owing to their advanced features and better reprocessing.

END-USER

The end-user market includes hospitals, specialty clinics & medical office suites, standalone service facilities, and others. In 2021, hospitals accounted for the highest share of the global endoscopy device cleaning market. The use of endoscopic devices is high ins hospitals as these perform an increased number of endoscopic procedures compared to other healthcare settings. However, standalone reprocessing service facilities will likely witness the fastest growth during the forecast period.

GEOGRAPHY

In 2021, North America accounted for the highest share of the global endoscope reprocessing market. Significant factors contributing to the growth of the endoscope reprocessing market share in the North American region include a rise in the number of endoscopic procedures performed, high demand for sterilizing and disinfecting endoscopic devices, increasing prevalence of digestive disorders, guidelines promoting safe procedures, and technological advancements in the systems and accessories. 

COMPETITIVE SCENARIO

The global market is highly competitive, with international, regional, and local players offering a broad range of products and accessories. Leading vendors such as STERIS, Ecolab, Getinge AB, Olympus, and ASP (acquired by Fortive) are coming up with several strategies such as partnerships, collaborations, joint ventures, mergers, and acquisitions for their growth and establishment in the industry.

For instance, STERIS recently agreed to acquire Cantel Medical, a global provider of infection prevention products and services primarily for endoscopy and dental customers.

Ecolab has developed vanBaerle, offering a full range of cleaning, disinfectant, and hygiene solutions, which can contribute to Ecolab's growth in cleaning and disinfectant products.

Product launches from these vendors are advancing the global endoscope reprocessing market. For instance, in 2020, Olympus launched its OER-Elite next-generation automated endoscope reprocessing system.

Frequently Asked Questions

How big is the global Endoscope Reprocessing Market?

The global endoscope reprocessing market is projected to grow at a CAGR of 8.37% reaching a market size of USD 3.3 billion in 2027 from USD 2.02 billion in 2021.

What are the key driving factors for the growth of the Endoscope Reprocessing Market?

Growing risk of developing endoscopy-related infections and increasing hospital investments in endoscopes & reprocessing systems will drive the industry growth.

Which region is anticipated to witness considerable growth in the endoscope reprocessing market?

The Asia-pacific region is expected to witness the fastest growth during the forecast period. However, the endoscope reprocessing market in North America will generate maximum revenue.

Which product is expected to hold the largest share in the endoscope reprocessing market?

In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market.

The global endoscope reprocessing market was valued at $2.02. billion in 2021 and is expected to reach $3.3 billion by 2027, growing at a CAGR of 8.37%.

The following factors are driving the global market growth.

  • Ease of FDA Evaluation & Approvals of Automated Endoscope Reprocessors
  • Rising Demand for Endoscopic Reprocessing Tracking Solutions
  • Technological Advancements in Endoscope Reprocessing

Base Year: 2021

Forecast Year: 2022–2027

The study considers the global market’s present scenario and dynamics for 2022−2027. It covers a detailed overview of several growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. 

Key Vendors:

  • STERIS
    • Business Overview
    • STERIS in Endoscope Reprocessing Market
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunites
  • Ecolab
  • Getinge AB
  • Olympus
  • Fortive

Other Prominent Vendors

  • 3M
    • Business Overview
    • Product Offerings
  • ATMS
  • Metall Zug
  • BES Healthcare
  • CONMED
  • Hoya
  • CREO Medical
  • Medalkan
  • Medical Devices
  • Metrex Research
  • PurposeBuilt
  • Richard Wolf
  • Summit Imaging
  • NanoSonics
  • Pentax medical
  • Mitra Group
  • CENSIS
  • Sympliant
  • Acuro Organics
  • Becto
  • Brulin
  • Cardinal Health
  • Cetylite
  • Contec
  • Hygiene-Konzepte
  • Lonza
  • Hako Group
  • Pharmax
  • The Clorox

Market Segments

Product:

  • Reprocessing Equipment
  • Disinfectants
  • Detergents
  • Drying, Storage & Transport Systems
  • Others

End-User

  • Hospitals
  • Specialty Clinics & Medical Office Suites
  • Standalone Reprocessing Service Facilities
  • Others:

Geography

North America

  • US
  • Canada

Europe

  • UK
  • France
  • Germany
  • Italy
  • Spain

APAC

  • Japan
  • China
  • India
  • South Korea
  • Australia

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • UAE
  • South Africa

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL ENDOSCOPE REPROCESSING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 SIMPLIFIED ILLUSTRATION OF ENDOSCOPE REPROCESSING CYCLE

EXHIBIT 4 DIFFERENT METHODS OF ENDOSCOPE REPROCESSING

EXHIBIT 5 MARKET DYNAMICS OF GLOBAL ENDOSCOPE REPROCESSING MARKET

EXHIBIT 6 SEGMENTATION OF GLOBAL ENDOSCOPE REPROCESSING MARKET

EXHIBIT 7 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY

EXHIBIT 8 IMPACT OF INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS

EXHIBIT 9 COMPLETED STATUS OF HLD OR LIQUID CHEMICAL STERILIZATION (LCS) VALIDATION TESTING OF AERS BY FDA

EXHIBIT 10 IMPACT OF DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS

EXHIBIT 11 MAJOR FEATURES OF ENDOSCOPE REPROCESSING TRACKING SOLUTIONS

EXHIBIT 12 IMPACT OF TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS

EXHIBIT 13 IMPACT OF INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS

EXHIBIT 14 IMPACT OF ENDOSCOPE-RELATED INFECTIONS

EXHIBIT 15 IMPACT OF REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING

EXHIBIT 16 IMPACT OF HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS

EXHIBIT 17 IMPACT OF HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT

EXHIBIT 18 IMPACT OF SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING

EXHIBIT 19 IMPACT OF SIDE EFFECTS OF DETERGENTS & DISINFECTANTS

EXHIBIT 20 IMPACT OF GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES

EXHIBIT 21 GLOBAL ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 22 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT

EXHIBIT 23 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT

EXHIBIT 24 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER

EXHIBIT 25 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY

EXHIBIT 26 FIVE FORCES ANALYSIS 2021

EXHIBIT 27 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 28 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT

EXHIBIT 29 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 30 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 31 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 32 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 34 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 35 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET 2021–2027 ($ MILLION)

EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 37 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET 2021–2027 ($ MILLION)

EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 40 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET 2021–2027 ($ MILLION)

EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 43 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 46 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 47 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET 2021–2027 ($ MILLION)

EXHIBIT 48 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 49 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 51 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 52 INCREMENTAL GROWTH BY SEGMENT 2021 & 2027

EXHIBIT 53 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER

EXHIBIT 54 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 55 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 57 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 58 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 59 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 60 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 62 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 63 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 64 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 65 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 66 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 69 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY

EXHIBIT 70 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)

EXHIBIT 71 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 72 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 73 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)

EXHIBIT 74 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 75 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 76 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 77 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027

EXHIBIT 78 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 80 US ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 81 CANADA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 82 EUROPE ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)

EXHIBIT 83 EUROPE ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 84 EUROPE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 85 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 86 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027

EXHIBIT 87 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 88 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 89 GERMANY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 90 UK ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 91 FRANCE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 92 ITALY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 93 SPAIN ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 94 APAC ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)

EXHIBIT 95 APAC ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 96 APAC ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 97 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 98 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027

EXHIBIT 99 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 101 CHINA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 102 JAPAN ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 103 INDIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 104 SOUTH KOREA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 105 AUSTRALIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 106 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)

EXHIBIT 107 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 108 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 109 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 110 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027

EXHIBIT 111 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 112 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 113 BRAZIL ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 114 MEXICO ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 115 ARGENTINA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 116 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)

EXHIBIT 117 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 118 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 119 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 120 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027

EXHIBIT 121 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 122 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 123 TURKEY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 124 SAUDI ARABIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 125 SOUTH AFRICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 126 UAE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)

EXHIBIT 127 PURE & DIVERSIFIED PLAYERS IN GLOBAL ENDOSCOPE REPROCESSING MARKET

EXHIBIT 128 POSITION OF MAJOR PLAYERS IN THE GLOBAL ENDOSCOPE REPROCESSING MARKET

EXHIBIT 129 GLOBAL ENDOSCOPE REPROCESSING MARKET: KEY VENDOR STRENGTHS & CAPABILITY ANALYSIS

EXHIBIT 130 STERIS: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 131 STERIS: REVENUE BY SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 132 STERIS: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 133 STERIS: REVENUE BY GEOGRAPHY 2019–2021 ($ MILLION)

EXHIBIT 134 ECOLAB: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 135 ECOLAB: REVENUE BY SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 136 ECOLAB: REVENUE BY R&D EXPENDITURE 2018–2020 ($ MILLION)

EXHIBIT 137 ECOLAB: REVENUE BY GEOGRAPHY (2020)

EXHIBIT 138 GETINGE AB: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 139 GETINGE AB: REVENUE BY GEOGRAPHY (2020)

EXHIBIT 140 OLYMPUS: REVENUE 2019–2021 ($ BILLION)

EXHIBIT 141 OLYMPUS: REVENUE SHARE BY DIVISION (2021)

EXHIBIT 142 : TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 143 : REVENUE BY SEGMENT 2019–2021 ($ MILLION)

EXHIBIT 144 : REVENUE BY R&D EXPENDITURE 2019–2021 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015–2021

TABLE 3 COMPARISON OF DIFFERENT AERS

TABLE 4 SPECIFIC RECOMMENDATIONS FOR REPROCESSING & STORAGE

TABLE 5 TOTAL ESTIMATED COST TO REPROCESS ONE ENDOSCOPE

TABLE 6 STERIS: MAJOR PRODUCT OFFERINGS

TABLE 7 ECOLAB: MAJOR PRODUCT OFFERINGS

TABLE 8 GETINGE: MAJOR PRODUCT OFFERINGS

TABLE 9 OLYMPUS: MAJOR PRODUCT OFFERINGS

TABLE 10 FORTIVE: MAJOR PRODUCT OFFERINGS

TABLE 11 3M: MAJOR PRODUCT OFFERINGS

TABLE 12 ACURO ORGANICS LIMITED: MAJOR PRODUCT OFFERINGS

TABLE 13 ATMS: MAJOR PRODUCT OFFERINGS

TABLE 14 BECTO: MAJOR PRODUCT OFFERINGS

TABLE 15 BES HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 16 BRULIN: MAJOR PRODUCT OFFERINGS

TABLE 17 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 18 CENSIS: MAJOR PRODUCT OFFERINGS

TABLE 19 CETYLITE: MAJOR PRODUCT OFFERINGS

TABLE 20 CONMED: MAJOR PRODUCT OFFERINGS

TABLE 21 CONTEC: MAJOR PRODUCT OFFERINGS

TABLE 22 CREO MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 23 HAKO GROUP: MAJOR PRODUCT OFFERINGS

TABLE 24 HOYA: MAJOR PRODUCT OFFERINGS

TABLE 25 HYGIENE-KONZEPTE: MAJOR PRODUCT OFFERINGS

TABLE 26 LONZA: MAJOR PRODUCT OFFERINGS

TABLE 27 MEDALKAN: MAJOR PRODUCT OFFERINGS

TABLE 28 MEDICAL DEVICES GROUP SRL: MAJOR PRODUCT OFFERINGS

TABLE 29 METALL ZUG AG: MAJOR PRODUCT OFFERINGS

TABLE 30 METREX RESEARCH: MAJOR PRODUCT OFFERINGS

TABLE 31 MITRA GROUP: MAJOR PRODUCT OFFERINGS

TABLE 32 NANOSONICS: MAJOR PRODUCT OFFERINGS

TABLE 33 PENTAX MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 34 PHARMAX: MAJOR PRODUCT OFFERINGS

TABLE 35 PURPOSEBUILT BRANDS: MAJOR PRODUCT OFFERINGS

TABLE 36 RICHARD WOLF GMBH: MAJOR PRODUCT OFFERINGS

TABLE 37 SUMMIT IMAGING: MAJOR PRODUCT OFFERINGS

TABLE 38 SYMPLIANT: MAJOR PRODUCT OFFERINGS

TABLE 39 THE CLOROX COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 40 TUTTNAUER: MAJOR PRODUCT OFFERINGS

TABLE 41 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 42 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 43 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 44 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 45 EUROPE ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 46 EUROPE ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 47 APAC ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 48 APAC ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 49 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 50 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 51 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)

TABLE 52 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)

TABLE 53 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 54 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 55 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 56 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 57 EUROPE ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 58 EUROPE ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 59 APAC ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 60 APAC ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 61 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 62 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 63 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)

TABLE 64 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)

TABLE 65 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 66 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 67 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 68 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 69 EUROPE ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 70 EUROPE ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 71 APAC ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 72 APAC ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 73 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 74 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 75 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 76 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)

TABLE 77 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 78 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 79 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 80 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 81 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 82 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 83 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 84 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 85 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 86 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 87 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 88 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 89 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 90 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 91 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 92 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 93 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 94 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 95 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 96 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 97 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 98 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 99 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 100 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY END-USER

4.3.3 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 PREMIUM INSIGHTS

8.1 OVERVIEW

8.1.1 ENDOSCOPE REPROCESSING MARKET

8.1.2 ENDOSCOPE REPROCESSING: MARKET SEGMENTATIONS

8.1.3 COMPETITIVE SCENARIO

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS

9.2 DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS

9.3 TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS

10 MARKET GROWTH ENABLERS

10.1 INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS

10.2 RISK OF ENDOSCOPE-RELATED INFECTIONS

10.3 REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING

10.4 HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS

11 MARKET RESTRAINTS

11.1 HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT

11.2 SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING

11.3 SIDE EFFECTS OF DETERGENTS & DISINFECTANTS

11.4 GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY PRODUCT

12.2.2 INSIGHTS BY ENDOSCOPE REPROCESSING EQUIPMENT

12.2.3 INSIGHTS BY END-USER

12.2.4 INSIGHTS BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

14 DISINFECTANTS

14.1 MARKET OVERVIEW

14.2 MARKET SIZE & FORECAST

14.2.1 DISINFECTANTS: MARKET BY GEOGRAPHY

15 REPROCESSING EQUIPMENT

15.1 MARKET OVERVIEW

15.2 MARKET SIZE & FORECAST

15.2.1 REPROCESSING EQUIPMENT: MARKET BY GEOGRAPHY

15.3 AUTOMATED ENDOSCOPE REPROCESSORS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 AUTOMATED ENDOSCOPE REPROCESSORS: MARKET BY GEOGRAPHY

15.4 DISINFECTION & STERILIZATION SYSTEMS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 DISINFECTION & STERILIZATION SYSTEMS: MARKET BY GEOGRAPHY

16 DETERGENTS

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.2.1 DETERGENTS: MARKET BY GEOGRAPHY

17 DRYING, STORAGE & TRANSPORT SYSTEMS

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.2.1 DRYING STORAGE, & TRANSPORT SYSTEMS: MARKET BY GEOGRAPHY

18 OTHERS

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.2.1 OTHERS: MARKET BY GEOGRAPHY

19 END-USER

19.1 MARKET SNAPSHOT & GROWTH ENGINE

19.2 MARKET OVERVIEW

19.3 HOSPITALS

19.3.1 MARKET OVERVIEW

19.3.2 MARKET SIZE & FORECAST

19.3.3 HOSPITALS: MARKET BY GEOGRAPHY

19.4 SPECIALTY CLINICS & MEDICAL OFFICE SUITES

19.4.1 MARKET OVERVIEW

19.4.2 MARKET SIZE & FORECAST

19.4.3 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: MARKET BY GEOGRAPHY

19.5 STANDALONE REPROCESSING SERVICE FACILITIES

19.5.1 MARKET OVERVIEW

19.5.2 MARKET SIZE & FORECAST

19.5.3 STANDALONE REPROCESSING SERVICE FACILITIES: MARKET BY GEOGRAPHY

19.6 OTHERS

19.6.1 MARKET OVERVIEW

19.6.2 MARKET SIZE & FORECAST

19.6.3 OTHERS: MARKET BY GEOGRAPHY

20 GEOGRAPHY

20.1 MARKET SNAPSHOT & GROWTH ENGINE

20.2 GEOGRAPHIC OVERVIEW

21 NORTH AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.2.1 NORTH AMERICA: PRODUCT

21.2.2 NORTH AMERICA: REPROCESSING EQUIPMENT

21.2.4 NORTH AMERICA: END-USER

21.3 KEY COUNTRIES

21.3.1 US: MARKET SIZE & FORECAST

21.3.2 CANADA: MARKET SIZE & FORECAST

22 EUROPE

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.2.1 EUROPE: PRODUCT

22.2.2 EUROPE: REPROCESSING EQUIPMENT

22.2.4 EUROPE: END-USER

22.3 KEY COUNTRIES

22.3.1 GERMANY: MARKET SIZE & FORECAST

22.3.2 UK: MARKET SIZE & FORECAST

22.3.3 FRANCE: MARKET SIZE & FORECAST

22.3.4 ITALY: MARKET SIZE & FORECAST

22.3.5 SPAIN: MARKET SIZE & FORECAST

23 APAC

23.1 MARKET OVERVIEW

23.2 MARKET SIZE & FORECAST

23.2.1 APAC: PRODUCT

23.2.2 APAC: REPROCESSING EQUIPMENT

23.2.4 APAC: END-USER

23.3 KEY COUNTRIES

23.3.1 CHINA: MARKET SIZE & FORECAST

23.3.2 JAPAN: MARKET SIZE & FORECAST

23.3.3 INDIA: MARKET SIZE & FORECAST

23.3.4 SOUTH KOREA: MARKET SIZE & FORECAST

23.3.5 AUSTRALIA: MARKET SIZE & FORECAST

24 LATIN AMERICA

24.1 MARKET OVERVIEW

24.2 MARKET SIZE & FORECAST

24.2.1 LATIN AMERICA: PRODUCT

24.2.2 LATIN AMERICA: REPROCESSING EQUIPMENT

24.2.4 LATIN AMERICA: END-USER

24.3 KEY COUNTRIES

24.3.1 BRAZIL: MARKET SIZE & FORECAST

24.3.2 MEXICO: MARKET SIZE & FORECAST

24.3.3 ARGENTINA: MARKET SIZE & FORECAST

25 MIDDLE EAST & AFRICA

25.1 MARKET OVERVIEW

25.2 MARKET SIZE & FORECAST

25.2.1 MIDDLE EAST & AFRICA: PRODUCT

25.2.2 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT

25.2.4 MIDDLE EAST & AFRICA: END-USER

25.3 KEY COUNTRIES

25.3.1 TURKEY: MARKET SIZE & FORECAST

25.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST

25.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

25.3.4 UAE: MARKET SIZE & FORECAST

26 COMPETITIVE LANDSCAPE

26.1 COMPETITION OVERVIEW

26.2 MARKET SHARE ANALYSIS

26.2.1 STERIS

26.2.2 ECOLAB

26.2.3 GETINGE

26.2.4 OLYMPUS

26.2.5 FORTIVE

27 KEY COMPANY PROFILES

27.1 STERIS

27.1.1 BUSINESS OVERVIEW

27.1.2 PRODUCT OFFERINGS

27.1.3 KEY STRATEGIES

27.1.4 KEY STRENGTHS

27.1.5 KEY OPPORTUNITIES

27.2 ECOLAB

27.2.1 BUSINESS OVERVIEW

27.2.2 PRODUCT OFFERINGS

27.2.3 KEY STRATEGIES

27.2.4 KEY STRENGTHS

27.2.5 KEY OPPORTUNITIES

27.3 GETINGE AB

27.3.1 BUSINESS OVERVIEW

27.3.2 PRODUCT OFFERINGS

27.3.3 KEY STRATEGIES

27.3.4 KEY STRENGTHS

27.3.5 KEY OPPORTUNITIES

27.4 OLYMPUS

27.4.1 BUSINESS OVERVIEW

27.4.2 PRODUCT OFFERINGS

27.4.3 KEY STRATEGIES

27.4.4 KEY STRENGTHS

27.4.5 KEY OPPORTUNITIES

27.5 FORTIVE

27.5.1 BUSINESS OVERVIEW

27.5.2 PRODUCT OFFERINGS

27.5.3 KEY STRATEGIES

27.5.4 KEY STRENGTHS

27.5.5 KEY OPPORTUNITIES

28 OTHER PROMINENT VENDORS

28.1 3M

28.1.1 BUSINESS OVERVIEW

28.1.2 PRODUCT OFFERINGS

28.2 ACURO ORGANICS LIMITED

28.2.1 BUSINESS OVERVIEW

28.2.2 PRODUCT OFFERINGS

28.3 ATMS

28.3.1 BUSINESS OVERVIEW

28.3.2 PRODUCT OFFERINGS

28.4 BECTO

28.4.1 BUSINESS OVERVIEW

28.4.2 PRODUCT OFFERINGS

28.5 BES HEALTHCARE

28.5.1 BUSINESS OVERVIEW

28.5.2 PRODUCT OFFERINGS

28.6 BRULIN

28.6.1 BUSINESS OVERVIEW

28.6.2 PRODUCT OFFERINGS

28.7 CARDINAL HEALTH

28.7.1 BUSINESS OVERVIEW

28.7.2 PRODUCT OFFERINGS

28.8 CENSIS

28.8.1 BUSINESS OVERVIEW

28.8.2 PRODUCT OFFERINGS

28.9 CETYLITE

28.9.1 BUSINESS OVERVIEW

28.9.2 PRODUCT OFFERINGS

28.10 CONMED

28.10.1 BUSINESS OVERVIEW

28.10.2 PRODUCT OFFERINGS

28.11 CONTEC

28.11.1 BUSINESS OVERVIEW

28.11.2 PRODUCT OFFERINGS

28.12 CREO MEDICAL

28.12.1 BUSINESS OVERVIEW

28.12.2 PRODUCT OFFERINGS

28.13 HAKO GROUP

28.13.1 BUSINESS OVERVIEW

28.13.2 PRODUCT OFFERINGS

28.14 HOYA

28.14.1 BUSINESS OVERVIEW

28.14.2 PRODUCT OFFERINGS

28.15 HYGIENE-KONZEPTE

28.15.1 BUSINESS OVERVIEW

28.15.2 PRODUCT OFFERINGS

28.16 LONZA

28.16.1 BUSINESS OVERVIEW

28.16.2 PRODUCT OFFERINGS

28.17 MEDALKAN

28.17.1 BUSINESS OVERVIEW

28.17.2 PRODUCT OFFERINGS

28.18 MEDICAL DEVICES GROUP SRL

28.18.1 BUSINESS OVERVIEW

28.18.2 PRODUCT OFFERINGS

28.19 METALL ZUG AG

28.19.1 BUSINESS OVERVIEW

28.19.2 PRODUCT OFFERINGS

28.20 METREX RESEARCH

28.20.1 BUSINESS OVERVIEW

28.20.2 PRODUCT OFFERINGS

28.21 MITRA GROUP

28.21.1 BUSINESS OVERVIEW

28.21.2 PRODUCT OFFERINGS

28.22 NANOSONICS

28.22.1 BUSINESS OVERVIEW

28.22.2 PRODUCT OFFERINGS

28.23 PENTAX MEDICAL

28.23.1 BUSINESS OVERVIEW

28.23.2 PRODUCT OFFERINGS

28.24 PHARMAX

28.24.1 BUSINESS OVERVIEW

28.24.2 PRODUCT OFFERINGS

28.25 PURPOSEBUILT BRANDS

28.25.1 BUSINESS OVERVIEW

28.25.2 PRODUCT OFFERINGS

28.26 RICHARD WOLF GMBH

28.26.1 BUSINESS OVERVIEW

28.26.2 PRODUCT OFFERINGS

28.27 SUMMIT IMAGING

28.27.1 BUSINESS OVERVIEW

28.27.2 PRODUCT OFFERINGS

28.28 SYMPLIANT

28.28.1 BUSINESS OVERVIEW

28.28.2 PRODUCT OFFERINGS

28.29 THE CLOROX COMPANY

28.29.1 BUSINESS OVERVIEW

28.29.2 PRODUCT OFFERINGS

28.30 TUTTNAUER

28.30.1 BUSINESS OVERVIEW

28.30.2 PRODUCT OFFERINGS

29 REPORT SUMMARY

29.1 KEY TAKEAWAYS

29.2 STRATEGIC RECOMMENDATIONS

30 QUANTITATIVE SUMMARY

30.1 MARKET BY PRODUCT

30.1.1 NORTH AMERICA: PRODUCT SEGMENTATION

30.1.2 EUROPE: PRODUCT SEGMENTATION

30.1.3 APAC: PRODUCT SEGMENTATION

30.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

30.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

30.2 MARKET BY REPROCESSING EQUIPMENT

30.2.1 NORTH AMERICA: REPROCESSING EQUIPMENT SEGMENTATION

30.2.2 EUROPE: REPROCESSING EQUIPMENT SEGMENTATION

30.2.3 APAC: REPROCESSING EQUIPMENT SEGMENTATION

30.2.4 LATIN AMERICA: REPROCESSING EQUIPMENT SEGMENTATION

30.2.5 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT SEGMENTATION

30.3 MARKET BY END-USER

30.3.1 NORTH AMERICA: END-USER SEGMENTATION

30.3.2 EUROPE: END-USER SEGMENTATION

30.3.3 APAC: END-USER SEGMENTATION

30.3.4 LATIN AMERICA: END-USER SEGMENTATION

30.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

30.4 MARKET BY GEOGRAPHY

30.4.1 DISINFECTANTS: GEOGRAPHY SEGMENTATION

30.4.2 REPROCESSING EQUIPMENT: GEOGRAPHY SEGMENTATION

30.4.3 DETERGENTS: GEOGRAPHY SEGMENTATION

30.4.4 DRYING, STORAGE, & TRANSPORT SYSTEMS: GEOGRAPHY SEGMENTATION

30.4.5 OTHERS: GEOGRAPHY SEGMENTATION

30.4.6 AUTOMATED ENDOSCOPE REPROCESSORS: GEOGRAPHY SEGMENTATION

30.4.7 DISINFECTION & STERILIZATION SYSTEMS: GEOGRAPHY SEGMENTATION

30.4.8 HOSPITALS: GEOGRAPHY SEGMENTATION

30.4.9 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: GEOGRAPHY SEGMENTATION

30.4.10 STANDALONE REPROCESSING SERVICE FACILITIES: GEOGRAPHY SEGMENTATION

30.4.11 OTHERS: GEOGRAPHY SEGMENTATION

31 APPENDIX

31.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the global Endoscope Reprocessing Market?

The global endoscope reprocessing market is projected to grow at a CAGR of 8.37% reaching a market size of USD 3.3 billion in 2027 from USD 2.02 billion in 2021.

What are the key driving factors for the growth of the Endoscope Reprocessing Market?

Growing risk of developing endoscopy-related infections and increasing hospital investments in endoscopes & reprocessing systems will drive the industry growth.

Which region is anticipated to witness considerable growth in the endoscope reprocessing market?

The Asia-pacific region is expected to witness the fastest growth during the forecast period. However, the endoscope reprocessing market in North America will generate maximum revenue.

Which product is expected to hold the largest share in the endoscope reprocessing market?

In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market.